ATE429518T1 - Zusammensetzungen und methoden zur vorbeugung transepithelialer übertragung von hiv - Google Patents

Zusammensetzungen und methoden zur vorbeugung transepithelialer übertragung von hiv

Info

Publication number
ATE429518T1
ATE429518T1 AT00944817T AT00944817T ATE429518T1 AT E429518 T1 ATE429518 T1 AT E429518T1 AT 00944817 T AT00944817 T AT 00944817T AT 00944817 T AT00944817 T AT 00944817T AT E429518 T1 ATE429518 T1 AT E429518T1
Authority
AT
Austria
Prior art keywords
icam
hiv
compositions
methods
transmission
Prior art date
Application number
AT00944817T
Other languages
English (en)
Inventor
Richard Markham
Kristen Khanna
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Application granted granted Critical
Publication of ATE429518T1 publication Critical patent/ATE429518T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT00944817T 1999-06-24 2000-06-23 Zusammensetzungen und methoden zur vorbeugung transepithelialer übertragung von hiv ATE429518T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14069899P 1999-06-24 1999-06-24
PCT/US2000/017293 WO2000079010A1 (en) 1999-06-24 2000-06-23 Compositions and methods for preventing transepithelial transmission of hiv

Publications (1)

Publication Number Publication Date
ATE429518T1 true ATE429518T1 (de) 2009-05-15

Family

ID=22492418

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00944817T ATE429518T1 (de) 1999-06-24 2000-06-23 Zusammensetzungen und methoden zur vorbeugung transepithelialer übertragung von hiv

Country Status (11)

Country Link
US (1) US6566095B1 (de)
EP (1) EP1190101B1 (de)
JP (1) JP4880153B2 (de)
CN (2) CN1402797A (de)
AT (1) ATE429518T1 (de)
AU (1) AU777241B2 (de)
CA (1) CA2377479C (de)
DE (1) DE60042069D1 (de)
DK (1) DK1190101T3 (de)
HK (1) HK1047300A1 (de)
WO (1) WO2000079010A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040021A2 (en) * 2000-11-17 2002-05-23 Idenix (Cayman) Limited Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
US20060063828A1 (en) * 2004-06-28 2006-03-23 Weingarten M D 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
EP1951306A4 (de) 2005-10-14 2010-08-11 Hopkins J School Of Medicine Verringerung und prävention von zellassoziierter hiv-transepithel-migration, mikrobizide und andere formulierungen und verfahren
BR112012025678A2 (pt) * 2010-04-09 2017-07-18 Immuron Ltd composição para inibição da transmissão do hiv, uso da mesma, métood para preparação da mesma e método para inibição de transmissão do hiv.
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US20120100186A1 (en) * 2010-10-20 2012-04-26 Washington University Nanoparticulate-based contraceptive/anti-hiv composition and methods
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284931A (en) 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
ATE219838T1 (de) 1989-03-16 2002-07-15 Blood Res Center Verwendung von funktionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie
ZA903223B (en) 1989-04-28 1991-02-27 Baylor College Medicine Dissemination of hiv-1 infected cells
WO1990013281A2 (en) 1989-04-28 1990-11-15 Baylor College Of Medicine Method of suppressing hiv infection
US5324510A (en) 1989-09-01 1994-06-28 Boehringer Ingelheim Pharmaceuticals, Inc. Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
GB9009549D0 (en) 1990-04-27 1990-06-20 Celltech Ltd Recombinant antibody and method
WO1991018010A1 (en) 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5629162A (en) * 1991-06-11 1997-05-13 The Center For Blood Research Method of identifying agents which modulate ICAM-3 binding to LFA-1
WO1993014776A1 (en) 1992-01-27 1993-08-05 Icos Corporation Icam-related protein
US5525487A (en) 1992-01-27 1996-06-11 Icos Corporation DNA encoding I-CAM related protein
US5532127A (en) 1992-01-27 1996-07-02 Icos Corporation Assay for 1-CAM related protein expression
AU675073B2 (en) * 1992-06-11 1997-01-23 Scripps Research Institute, The Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
US5651970A (en) 1993-03-19 1997-07-29 Allen; Allen D. Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics
US5733540A (en) 1995-03-08 1998-03-31 Lee; Peter Poon-Hang Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria

Also Published As

Publication number Publication date
DK1190101T3 (da) 2009-08-03
CN1402797A (zh) 2003-03-12
AU5885500A (en) 2001-01-09
AU777241B2 (en) 2004-10-07
HK1047300A1 (zh) 2003-02-14
DE60042069D1 (de) 2009-06-04
EP1190101A4 (de) 2004-09-15
EP1190101A1 (de) 2002-03-27
JP4880153B2 (ja) 2012-02-22
EP1190101B1 (de) 2009-04-22
US6566095B1 (en) 2003-05-20
WO2000079010A1 (en) 2000-12-28
JP2003513007A (ja) 2003-04-08
CA2377479C (en) 2011-01-11
CA2377479A1 (en) 2000-12-28
CN101912610A (zh) 2010-12-15

Similar Documents

Publication Publication Date Title
TR200003011T2 (tr) Yeni dihidropirimidinler.
ATE227983T1 (de) Methoden zur verhütung von kristallwachstum und partikelaggregation in nanopartikelzusammensetzungen
DK1157037T3 (da) GCSF-konjugater
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
KR0179637B1 (en) Diaromatic substituted compounds as anti-hiv-1 agents
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
DE69917477D1 (de) Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
TR200100054T2 (tr) Paroksetin metansülfonat
DE69932510D1 (de) Vaskularisierungsinhibitoren
PT933993E (pt) Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
ATE86858T1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
IT1302682B1 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DE69928779D1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
DE69911023D1 (de) Antagonisten des gonadotropin freisetzenden hormons
DE60042069D1 (de) Zusammensetzungen und methoden zur vorbeugung transepithelialer übertragung von hiv
NO994043D0 (no) Avrivbar emballasje med forseglet kant i barnesikker utforming, fremgangsmÕte for fremstilling og anvendelse av den samme
AR026637A1 (es) Virus atenuados e inocuos de la diarrea virica bovina para uso en vacas gestantes
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
GT199900062A (es) Preparados efervescentes.
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon
ATE278461T1 (de) Mikropartikel hergestellt aus cycloolefincopolymeren und deren verwendung zur kontrollierten wirkstofffreigabe
FR2793702B1 (fr) Compositions utilisables comme agents de surface emulsifiants et dispersants, leur preparation et leurs utilisations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties